Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide.
about
Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Medication Adherence, Treatmen ...... erone Acetate or Enzalutamide.
@en
Medication Adherence, Treatmen ...... erone Acetate or Enzalutamide.
@nl
type
label
Medication Adherence, Treatmen ...... erone Acetate or Enzalutamide.
@en
Medication Adherence, Treatmen ...... erone Acetate or Enzalutamide.
@nl
prefLabel
Medication Adherence, Treatmen ...... erone Acetate or Enzalutamide.
@en
Medication Adherence, Treatmen ...... erone Acetate or Enzalutamide.
@nl
P2093
P2860
P1476
Medication Adherence, Treatmen ...... erone Acetate or Enzalutamide.
@en
P2093
Ajay S Behl
Dominic Pilon
Lorie A Ellis
Patrick Lefebvre
Yongling Xiao
P2860
P304
P577
2017-09-01T00:00:00Z